AbbVie Allergan Aesthetics has filed a material event with the SEC, typically indicating a significant change to business operations, pricing, or loyalty programs. Given Allergan's dominance in neuromodulators and dermal fillers, any material shift in Botox, Juvéderm, or Allē program terms will ripple across the entire medspa industry.